4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000150
Director sold 1,666 shares at $23.39 ($38,968)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-12-15 | Sale 10b5-1 | −1,666 | $23.39 | $38,968 | 124,707 | D: show line 1 in the form |
| Open-market sales · 1,666 sh · avg $23.39 · $38,968 | |||||||
Loading xslF345X05/wk-form4_1702945827.xml…